Finance

Shares of Moderna skyrocketed over 175% to achieve its best trading session on record following highly successful late-stage trial results for an experimental melanoma vaccine co-developed with Merck. The massive rally significantly boosted the broader healthcare sector, helping to insulate the primary stock indexes from ongoing volatility.

Despite a broader market recovery, artificial intelligence and chipmaking hardware equities experienced considerable downward friction. Investor sentiment was dampened by reports of expanding losses at OpenAI, paired with a steep 4.6% decline in Broadcom as market participants question whether the hefty investments in AI infrastructure will translate into sufficient near-term corporate earnings.

The digital asset space saw renewed momentum as Bitcoin surged more than 8% to reclaim the $70,000 threshold for the first time since early June. Cryptocurrencies capitalized heavily on a broad global risk-on attitude sparked by the cooling of Treasury yields and a subsequent downward slide in the value of the U.S. dollar.